Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing

MLA

Eric Alves, et al. “Reprogramming the Anti-Tumor Immune Response via CRISPR Genetic and Epigenetic Editing.” Molecular Therapy: Methods & Clinical Development, vol. 21, no. 592–606, June 2021, pp. 592–606. EBSCOhost, https://doi.org/10.1016/j.omtm.2021.04.009.

APA

Eric Alves, Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri, & Pilar Blancafort. (2021). Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing. Molecular Therapy: Methods & Clinical Development, 21(592–606), 592–606. https://doi.org/10.1016/j.omtm.2021.04.009

Chicago

Eric Alves, Shahama Taifour, Riccardo Dolcetti, Jonathan Chee, Anna K. Nowak, Silvana Gaudieri, and Pilar Blancafort. 2021. “Reprogramming the Anti-Tumor Immune Response via CRISPR Genetic and Epigenetic Editing.” Molecular Therapy: Methods & Clinical Development 21 (592–606): 592–606. doi:10.1016/j.omtm.2021.04.009.